Loading…
Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer
Purpose The oncogenic roles of sphingosine kinase 1 (SphK1) in various cancers, including thyroid cancer, have been well demonstrated. However, the microRNAs (miRNAs) associated with the oncogenic roles of SphK1 remain largely unknown. Methods Global gene and miRNA expression in TPC1-Vector and TPC1...
Saved in:
Published in: | Journal of cancer research and clinical oncology 2017-04, Vol.143 (4), p.601-611 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c372t-e77a440eee5a1904b4820bb836fda00e9144e99ae1b9dd3e2b7d8161c688134b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c372t-e77a440eee5a1904b4820bb836fda00e9144e99ae1b9dd3e2b7d8161c688134b3 |
container_end_page | 611 |
container_issue | 4 |
container_start_page | 601 |
container_title | Journal of cancer research and clinical oncology |
container_volume | 143 |
creator | Liang, Weiwei Xie, Zhiwei Cui, Weiling Guo, Yan Xu, Lijuan Wu, Jueheng Guan, Hongyu |
description | Purpose
The oncogenic roles of sphingosine kinase 1 (SphK1) in various cancers, including thyroid cancer, have been well demonstrated. However, the microRNAs (miRNAs) associated with the oncogenic roles of SphK1 remain largely unknown.
Methods
Global gene and miRNA expression in TPC1-Vector and TPC1-SphK1 cells was analyzed using digital gene expression (DGE) analysis and small RNA-seq, respectively. miRNA–mRNA interactions were explored by microT-CDS, and the predicted networks were visualized using CytoScape
®
. Cell invasion and migration were assessed by performing Transwell invasion and wound-healing assays. Luciferase reporter and immunoblot assays were used to evaluate the targeting of fibronectin 1 (FN1) by miR-144-3p.
Results
In this study, we found that overexpression of SphK1 differentially regulates the expression of 46 miRNAs and 506 mRNAs in papillary thyroid cancer (PTC) TPC1 cells. Combining bioinformatics predictions of mRNA targets with DGE data on mRNA expression allowed us to identify the mRNA targets of deregulated miRNAs. The direct interaction between miR-144-3p and FN1, which mediates the pro-invasive role of SphK1 in PTC cells, was experimentally validated.
Conclusions
Our results demonstrated that SphK1 overexpression drives a regulatory network governing miRNA and mRNA expression in PTC cells. We also demonstrated the roles played by miR-144-3p and FN1 in mediating the oncogenic function of SphK1, which enhanced the understanding of the etiology of PTC. |
doi_str_mv | 10.1007/s00432-016-2315-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1852662863</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4320828021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-e77a440eee5a1904b4820bb836fda00e9144e99ae1b9dd3e2b7d8161c688134b3</originalsourceid><addsrcrecordid>eNp1kc9u1DAQxi1ERbeFB-BSWeLCJa3HduLkWK0KRa2KxJ-z5SSTXVeJHezdFX0FnppZtqCqEifL_n7zeWY-xt6COAchzEUWQitZCKgKqaAsxAu2gP0LKFW-ZAsBBopSQnXMTnK-F3QvjXzFjqVptKwrsWC_lnGaE64xZL9DvsKA3IWeT75L8cvdJcefJOfsY-BzioMffVjxhDt0Y-aOpzgiH2KiAqIz94Fv1shj6CJ5-e4PkHkc-Nd5fQN7fXazH0eXHoh8SNH3vHOhw_SaHQ1kim8ez1P2_cPVt-V1cfv546fl5W3RKSM3BRrjtBaIWDpohG51LUXb1qoaeicENqA1No1DaJu-Vyhb09dQQVfVNSjdqlP2_uBL8_zYYt7YyecOqaWAcZst1KWsKlqPIvTdM_Q-blOg7ogyxkgjtSQKDhStLOeEg52Tn2hAC8Lug7KHoCwFZfdBWUE1Z4_O23bC_l_F32QIkAcgkxRWmJ58_V_X3y-FnlY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1877727242</pqid></control><display><type>article</type><title>Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer</title><source>Springer Nature</source><creator>Liang, Weiwei ; Xie, Zhiwei ; Cui, Weiling ; Guo, Yan ; Xu, Lijuan ; Wu, Jueheng ; Guan, Hongyu</creator><creatorcontrib>Liang, Weiwei ; Xie, Zhiwei ; Cui, Weiling ; Guo, Yan ; Xu, Lijuan ; Wu, Jueheng ; Guan, Hongyu</creatorcontrib><description>Purpose
The oncogenic roles of sphingosine kinase 1 (SphK1) in various cancers, including thyroid cancer, have been well demonstrated. However, the microRNAs (miRNAs) associated with the oncogenic roles of SphK1 remain largely unknown.
Methods
Global gene and miRNA expression in TPC1-Vector and TPC1-SphK1 cells was analyzed using digital gene expression (DGE) analysis and small RNA-seq, respectively. miRNA–mRNA interactions were explored by microT-CDS, and the predicted networks were visualized using CytoScape
®
. Cell invasion and migration were assessed by performing Transwell invasion and wound-healing assays. Luciferase reporter and immunoblot assays were used to evaluate the targeting of fibronectin 1 (FN1) by miR-144-3p.
Results
In this study, we found that overexpression of SphK1 differentially regulates the expression of 46 miRNAs and 506 mRNAs in papillary thyroid cancer (PTC) TPC1 cells. Combining bioinformatics predictions of mRNA targets with DGE data on mRNA expression allowed us to identify the mRNA targets of deregulated miRNAs. The direct interaction between miR-144-3p and FN1, which mediates the pro-invasive role of SphK1 in PTC cells, was experimentally validated.
Conclusions
Our results demonstrated that SphK1 overexpression drives a regulatory network governing miRNA and mRNA expression in PTC cells. We also demonstrated the roles played by miR-144-3p and FN1 in mediating the oncogenic function of SphK1, which enhanced the understanding of the etiology of PTC.</description><identifier>ISSN: 0171-5216</identifier><identifier>EISSN: 1432-1335</identifier><identifier>DOI: 10.1007/s00432-016-2315-0</identifier><identifier>PMID: 27942860</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cancer Research ; Carcinoma - genetics ; Carcinoma, Papillary ; Cellular biology ; Gene expression ; Gene Expression Profiling ; Hematology ; Humans ; Internal Medicine ; Kinases ; Medicine ; Medicine & Public Health ; MicroRNAs ; MicroRNAs - genetics ; Oncogenes ; Oncology ; Original Article – Cancer Research ; Phosphotransferases (Alcohol Group Acceptor) - genetics ; Thyroid cancer ; Thyroid Cancer, Papillary ; Thyroid Neoplasms - genetics</subject><ispartof>Journal of cancer research and clinical oncology, 2017-04, Vol.143 (4), p.601-611</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><rights>Journal of Cancer Research and Clinical Oncology is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-e77a440eee5a1904b4820bb836fda00e9144e99ae1b9dd3e2b7d8161c688134b3</citedby><cites>FETCH-LOGICAL-c372t-e77a440eee5a1904b4820bb836fda00e9144e99ae1b9dd3e2b7d8161c688134b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27942860$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liang, Weiwei</creatorcontrib><creatorcontrib>Xie, Zhiwei</creatorcontrib><creatorcontrib>Cui, Weiling</creatorcontrib><creatorcontrib>Guo, Yan</creatorcontrib><creatorcontrib>Xu, Lijuan</creatorcontrib><creatorcontrib>Wu, Jueheng</creatorcontrib><creatorcontrib>Guan, Hongyu</creatorcontrib><title>Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer</title><title>Journal of cancer research and clinical oncology</title><addtitle>J Cancer Res Clin Oncol</addtitle><addtitle>J Cancer Res Clin Oncol</addtitle><description>Purpose
The oncogenic roles of sphingosine kinase 1 (SphK1) in various cancers, including thyroid cancer, have been well demonstrated. However, the microRNAs (miRNAs) associated with the oncogenic roles of SphK1 remain largely unknown.
Methods
Global gene and miRNA expression in TPC1-Vector and TPC1-SphK1 cells was analyzed using digital gene expression (DGE) analysis and small RNA-seq, respectively. miRNA–mRNA interactions were explored by microT-CDS, and the predicted networks were visualized using CytoScape
®
. Cell invasion and migration were assessed by performing Transwell invasion and wound-healing assays. Luciferase reporter and immunoblot assays were used to evaluate the targeting of fibronectin 1 (FN1) by miR-144-3p.
Results
In this study, we found that overexpression of SphK1 differentially regulates the expression of 46 miRNAs and 506 mRNAs in papillary thyroid cancer (PTC) TPC1 cells. Combining bioinformatics predictions of mRNA targets with DGE data on mRNA expression allowed us to identify the mRNA targets of deregulated miRNAs. The direct interaction between miR-144-3p and FN1, which mediates the pro-invasive role of SphK1 in PTC cells, was experimentally validated.
Conclusions
Our results demonstrated that SphK1 overexpression drives a regulatory network governing miRNA and mRNA expression in PTC cells. We also demonstrated the roles played by miR-144-3p and FN1 in mediating the oncogenic function of SphK1, which enhanced the understanding of the etiology of PTC.</description><subject>Cancer Research</subject><subject>Carcinoma - genetics</subject><subject>Carcinoma, Papillary</subject><subject>Cellular biology</subject><subject>Gene expression</subject><subject>Gene Expression Profiling</subject><subject>Hematology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>Oncogenes</subject><subject>Oncology</subject><subject>Original Article – Cancer Research</subject><subject>Phosphotransferases (Alcohol Group Acceptor) - genetics</subject><subject>Thyroid cancer</subject><subject>Thyroid Cancer, Papillary</subject><subject>Thyroid Neoplasms - genetics</subject><issn>0171-5216</issn><issn>1432-1335</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kc9u1DAQxi1ERbeFB-BSWeLCJa3HduLkWK0KRa2KxJ-z5SSTXVeJHezdFX0FnppZtqCqEifL_n7zeWY-xt6COAchzEUWQitZCKgKqaAsxAu2gP0LKFW-ZAsBBopSQnXMTnK-F3QvjXzFjqVptKwrsWC_lnGaE64xZL9DvsKA3IWeT75L8cvdJcefJOfsY-BzioMffVjxhDt0Y-aOpzgiH2KiAqIz94Fv1shj6CJ5-e4PkHkc-Nd5fQN7fXazH0eXHoh8SNH3vHOhw_SaHQ1kim8ez1P2_cPVt-V1cfv546fl5W3RKSM3BRrjtBaIWDpohG51LUXb1qoaeicENqA1No1DaJu-Vyhb09dQQVfVNSjdqlP2_uBL8_zYYt7YyecOqaWAcZst1KWsKlqPIvTdM_Q-blOg7ogyxkgjtSQKDhStLOeEg52Tn2hAC8Lug7KHoCwFZfdBWUE1Z4_O23bC_l_F32QIkAcgkxRWmJ58_V_X3y-FnlY</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Liang, Weiwei</creator><creator>Xie, Zhiwei</creator><creator>Cui, Weiling</creator><creator>Guo, Yan</creator><creator>Xu, Lijuan</creator><creator>Wu, Jueheng</creator><creator>Guan, Hongyu</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20170401</creationdate><title>Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer</title><author>Liang, Weiwei ; Xie, Zhiwei ; Cui, Weiling ; Guo, Yan ; Xu, Lijuan ; Wu, Jueheng ; Guan, Hongyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-e77a440eee5a1904b4820bb836fda00e9144e99ae1b9dd3e2b7d8161c688134b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cancer Research</topic><topic>Carcinoma - genetics</topic><topic>Carcinoma, Papillary</topic><topic>Cellular biology</topic><topic>Gene expression</topic><topic>Gene Expression Profiling</topic><topic>Hematology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>Oncogenes</topic><topic>Oncology</topic><topic>Original Article – Cancer Research</topic><topic>Phosphotransferases (Alcohol Group Acceptor) - genetics</topic><topic>Thyroid cancer</topic><topic>Thyroid Cancer, Papillary</topic><topic>Thyroid Neoplasms - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liang, Weiwei</creatorcontrib><creatorcontrib>Xie, Zhiwei</creatorcontrib><creatorcontrib>Cui, Weiling</creatorcontrib><creatorcontrib>Guo, Yan</creatorcontrib><creatorcontrib>Xu, Lijuan</creatorcontrib><creatorcontrib>Wu, Jueheng</creatorcontrib><creatorcontrib>Guan, Hongyu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liang, Weiwei</au><au>Xie, Zhiwei</au><au>Cui, Weiling</au><au>Guo, Yan</au><au>Xu, Lijuan</au><au>Wu, Jueheng</au><au>Guan, Hongyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer</atitle><jtitle>Journal of cancer research and clinical oncology</jtitle><stitle>J Cancer Res Clin Oncol</stitle><addtitle>J Cancer Res Clin Oncol</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>143</volume><issue>4</issue><spage>601</spage><epage>611</epage><pages>601-611</pages><issn>0171-5216</issn><eissn>1432-1335</eissn><abstract>Purpose
The oncogenic roles of sphingosine kinase 1 (SphK1) in various cancers, including thyroid cancer, have been well demonstrated. However, the microRNAs (miRNAs) associated with the oncogenic roles of SphK1 remain largely unknown.
Methods
Global gene and miRNA expression in TPC1-Vector and TPC1-SphK1 cells was analyzed using digital gene expression (DGE) analysis and small RNA-seq, respectively. miRNA–mRNA interactions were explored by microT-CDS, and the predicted networks were visualized using CytoScape
®
. Cell invasion and migration were assessed by performing Transwell invasion and wound-healing assays. Luciferase reporter and immunoblot assays were used to evaluate the targeting of fibronectin 1 (FN1) by miR-144-3p.
Results
In this study, we found that overexpression of SphK1 differentially regulates the expression of 46 miRNAs and 506 mRNAs in papillary thyroid cancer (PTC) TPC1 cells. Combining bioinformatics predictions of mRNA targets with DGE data on mRNA expression allowed us to identify the mRNA targets of deregulated miRNAs. The direct interaction between miR-144-3p and FN1, which mediates the pro-invasive role of SphK1 in PTC cells, was experimentally validated.
Conclusions
Our results demonstrated that SphK1 overexpression drives a regulatory network governing miRNA and mRNA expression in PTC cells. We also demonstrated the roles played by miR-144-3p and FN1 in mediating the oncogenic function of SphK1, which enhanced the understanding of the etiology of PTC.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27942860</pmid><doi>10.1007/s00432-016-2315-0</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0171-5216 |
ispartof | Journal of cancer research and clinical oncology, 2017-04, Vol.143 (4), p.601-611 |
issn | 0171-5216 1432-1335 |
language | eng |
recordid | cdi_proquest_miscellaneous_1852662863 |
source | Springer Nature |
subjects | Cancer Research Carcinoma - genetics Carcinoma, Papillary Cellular biology Gene expression Gene Expression Profiling Hematology Humans Internal Medicine Kinases Medicine Medicine & Public Health MicroRNAs MicroRNAs - genetics Oncogenes Oncology Original Article – Cancer Research Phosphotransferases (Alcohol Group Acceptor) - genetics Thyroid cancer Thyroid Cancer, Papillary Thyroid Neoplasms - genetics |
title | Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A56%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comprehensive%20gene%20and%20microRNA%20expression%20profiling%20reveals%20a%20role%20for%20miRNAs%20in%20the%20oncogenic%20roles%20of%20SphK1%20in%20papillary%20thyroid%20cancer&rft.jtitle=Journal%20of%20cancer%20research%20and%20clinical%20oncology&rft.au=Liang,%20Weiwei&rft.date=2017-04-01&rft.volume=143&rft.issue=4&rft.spage=601&rft.epage=611&rft.pages=601-611&rft.issn=0171-5216&rft.eissn=1432-1335&rft_id=info:doi/10.1007/s00432-016-2315-0&rft_dat=%3Cproquest_cross%3E4320828021%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-e77a440eee5a1904b4820bb836fda00e9144e99ae1b9dd3e2b7d8161c688134b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1877727242&rft_id=info:pmid/27942860&rfr_iscdi=true |